Exagen (XGN) Free Cash Flow Growth (1y) (2019 - 2026)
Exagen (XGN) Free Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 16.06% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 112.68% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 23.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -20.33% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 33.01% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 5.28% |
| 10 | Exagen | 158.28 Mn | 133.68 Mn | 12.22 Mn | 213.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 213.66% |
| Mar 31, 2026 | 3.30% |
| Dec 31, 2025 | -377.23% |
| Sep 30, 2025 | 229.65% |
| Jun 30, 2025 | -23.26% |
| Mar 31, 2025 | -19.91% |
| Dec 31, 2024 | -90.49% |
| Sep 30, 2024 | 13.23% |
| Jun 30, 2024 | 75.84% |
| Mar 31, 2024 | 7.96% |
| Dec 31, 2023 | 188.91% |
| Sep 30, 2023 | 59.47% |
| Jun 30, 2023 | 0.90% |
| Mar 31, 2023 | -1.73% |
| Dec 31, 2022 | -32.29% |
| Sep 30, 2022 | -6.76% |
| Jun 30, 2022 | -128.53% |
| Mar 31, 2022 | -121.58% |
| Dec 31, 2021 | -77.69% |
| Sep 30, 2021 | -159.32% |